Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphomaYi Xia, Ken H. Young, Ganiraju C. Manyam et al.|Leukemia|2016Cited by 64
Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapyZhiwen Yao, Ken H. Young, Lijuan Deng et al.|Leukemia|2017Cited by 56